| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |